Metabolomics in nephrotoxicity - PubMed (original) (raw)

PMID: 25233611

Review

Metabolomics in nephrotoxicity

Ying-Yong Zhao et al. Adv Clin Chem. 2014.

Abstract

Nephrotoxicity or renal toxicity can be a result of hemodynamic changes, direct injury to cells and tissue, inflammatory tissue injury, and/or obstruction of renal excretion. Nephrotoxicity is frequently induced by a wide spectrum of therapeutic drugs and environ mental pollutants. Knowledge of the complex molecular and pathophysiologic mechanisms leading to nephrotoxicity remains limited, in part, by research that historically focused on single or relatively few risk markers. As such, current kidney injury biomarkers are inadequate in terms of sensitivity and specificity. In contrast, metabolomics enables screening of a vast array of metabolites simultaneously using NMR and MS to assess their role in nephrotoxicity development and progression. A more comprehensive understanding of these biochemical pathways would also provide valuable insight to disease mechanisms critical for drug development and treatment.

PubMed Disclaimer

Cited by

RefMetaPlant: a reference metabolome database for plants across five major phyla.
Shi H, Wu X, Zhu Y, Jiang T, Wang Z, Li X, Liu J, Zhang Y, Chen F, Gao J, Xu X, Zhang G, Xiao N, Feng X, Zhang P, Wu Y, Li A, Chen P, Li X. Shi H, et al. Nucleic Acids Res. 2024 Jan 5;52(D1):D1614-D1628. doi: 10.1093/nar/gkad980. Nucleic Acids Res. 2024. PMID: 37953341 Free PMC article.
The Role of miRNA in Renal Fibrosis Leading to Chronic Kidney Disease.
Gluba-Sagr A, Franczyk B, Rysz-Górzyńska M, Ławiński J, Rysz J. Gluba-Sagr A, et al. Biomedicines. 2023 Aug 23;11(9):2358. doi: 10.3390/biomedicines11092358. Biomedicines. 2023. PMID: 37760798 Free PMC article. Review.
Lipidomic and Metabolomic Signature of Progression of Chronic Kidney Disease in Patients with Severe Obesity.
Lanzon B, Martin-Taboada M, Castro-Alves V, Vila-Bedmar R, González de Pablos I, Duberg D, Gomez P, Rodriguez E, Orešič M, Hyötyläinen T, Morales E, Ruperez FJ, Medina-Gomez G. Lanzon B, et al. Metabolites. 2021 Dec 3;11(12):836. doi: 10.3390/metabo11120836. Metabolites. 2021. PMID: 34940593 Free PMC article.
Lipidomics Reveals Cisplatin-Induced Renal Lipid Alterations during Acute Kidney Injury and Their Attenuation by Cilastatin.
Moreno-Gordaliza E, Marazuela MD, Pastor Ó, Lázaro A, Gómez-Gómez MM. Moreno-Gordaliza E, et al. Int J Mol Sci. 2021 Nov 20;22(22):12521. doi: 10.3390/ijms222212521. Int J Mol Sci. 2021. PMID: 34830406 Free PMC article.
Serum metabolomics of end-stage renal disease patients with depression: potential biomarkers for diagnosis.
Yuan D, Kuan T, Ling H, Wang H, Feng L, Zhao Q, Li J, Ran J. Yuan D, et al. Ren Fail. 2021 Dec;43(1):1479-1491. doi: 10.1080/0886022X.2021.1994995. Ren Fail. 2021. PMID: 34723750 Free PMC article.

Metabolomics in nephrotoxicity - PubMed (original) (raw)